114 related articles for article (PubMed ID: 2062450)
1. Central serotonergic S2 binding in Papio anubis measured in vivo with N-omega-[18F]fluoroethylketanserin and PET.
Moerlein SM; Perlmutter JS
Neurosci Lett; 1991 Feb; 123(1):23-6. PubMed ID: 2062450
[TBL] [Abstract][Full Text] [Related]
2. Specific binding of 3N-(2'-[18F]fluoroethyl)benperidol to primate cerebral dopaminergic D2 receptors demonstrated in vivo by PET.
Moerlein SM; Perlmutter JS
Neurosci Lett; 1992 Dec; 148(1-2):97-100. PubMed ID: 1300511
[TBL] [Abstract][Full Text] [Related]
3. [18F]setoperone: a new high-affinity ligand for positron emission tomography study of the serotonin-2 receptors in baboon brain in vivo.
Blin J; Pappata S; Kiyosawa M; Crouzel C; Baron JC
Eur J Pharmacol; 1988 Feb; 147(1):73-82. PubMed ID: 3259509
[TBL] [Abstract][Full Text] [Related]
4. Serotonin 5HT2 receptor imaging in the human brain using positron emission tomography and a new radioligand, [18F]altanserin: results in young normal controls.
Sadzot B; Lemaire C; Maquet P; Salmon E; Plenevaux A; Degueldre C; Hermanne JP; Guillaume M; Cantineau R; Comar D
J Cereb Blood Flow Metab; 1995 Sep; 15(5):787-97. PubMed ID: 7673371
[TBL] [Abstract][Full Text] [Related]
5. Non-steady-state measurement of in vivo radioligand binding with positron emission tomography: specificity analysis and comparison with in vitro binding.
Perlmutter JS; Moerlein SM; Hwang DR; Todd RD
J Neurosci; 1991 May; 11(5):1381-9. PubMed ID: 1827499
[TBL] [Abstract][Full Text] [Related]
6. Binding of 5-(2'-[18F]fluoroethyl)flumazenil to central benzodiazepine receptors measured in living baboon by positron emission tomography.
Moerlein SM; Perlmutter JS
Eur J Pharmacol; 1992 Jul; 218(1):109-15. PubMed ID: 1327820
[TBL] [Abstract][Full Text] [Related]
7. Specific, reversible binding of [18F]benperidol to baboon D2 receptors: PET evaluation of an improved 18F-labeled ligand.
Moerlein SM; Perlmutter JS; Welch MJ
Nucl Med Biol; 1995 Aug; 22(6):809-15. PubMed ID: 8535343
[TBL] [Abstract][Full Text] [Related]
8. Test-retest variability of serotonin 5-HT2A receptor binding measured with positron emission tomography and [18F]altanserin in the human brain.
Smith GS; Price JC; Lopresti BJ; Huang Y; Simpson N; Holt D; Mason NS; Meltzer CC; Sweet RA; Nichols T; Sashin D; Mathis CA
Synapse; 1998 Dec; 30(4):380-92. PubMed ID: 9826230
[TBL] [Abstract][Full Text] [Related]
9. A method for the in vivo investigation of the serotonergic 5-HT2 receptors in the human cerebral cortex using positron emission tomography and 18F-labeled setoperone.
Blin J; Sette G; Fiorelli M; Bletry O; Elghozi JL; Crouzel C; Baron JC
J Neurochem; 1990 May; 54(5):1744-54. PubMed ID: 2182776
[TBL] [Abstract][Full Text] [Related]
10. PET measurement of D2 and S2 receptor binding of 3-N-[( 2'-18F]fluoroethyl)spiperone in baboon brain.
Coenen HH; Wienhard K; Stöcklin G; Laufer P; Hebold I; Pawlik G; Heiss WD
Eur J Nucl Med; 1988; 14(2):80-7. PubMed ID: 2968911
[TBL] [Abstract][Full Text] [Related]
11. Fluorine-18-altanserin: a radioligand for the study of serotonin receptors with PET: radiolabeling and in vivo biologic behavior in rats.
Lemaire C; Cantineau R; Guillaume M; Plenevaux A; Christiaens L
J Nucl Med; 1991 Dec; 32(12):2266-72. PubMed ID: 1744713
[TBL] [Abstract][Full Text] [Related]
12. Characterization of radioactive metabolites of 5-HT2A receptor PET ligand [18F]altanserin in human and rodent.
Tan PZ; Baldwin RM; Van Dyck CH; Al-Tikriti M; Roth B; Khan N; Charney DS; Innis RB
Nucl Med Biol; 1999 Aug; 26(6):601-8. PubMed ID: 10587097
[TBL] [Abstract][Full Text] [Related]
13. Localization of serotonin 5-HT2 receptors in living human brain by positron emission tomography using N1-([11C]-methyl)-2-Br-LSD.
Wong DF; Lever JR; Hartig PR; Dannals RF; Villemagne V; Hoffman BJ; Wilson AA; Ravert HT; Links JM; Scheffel U
Synapse; 1987; 1(5):393-8. PubMed ID: 2905532
[TBL] [Abstract][Full Text] [Related]
14. Comparison of [(18)F]altanserin and [(18)F]deuteroaltanserin for PET imaging of serotonin(2A) receptors in baboon brain: pharmacological studies.
Staley JK; Van Dyck CH; Tan PZ; Al Tikriti M; Ramsby Q; Klump H; Ng C; Garg P; Soufer R; Baldwin RM; Innis RB
Nucl Med Biol; 2001 Apr; 28(3):271-9. PubMed ID: 11323237
[TBL] [Abstract][Full Text] [Related]
15. Equilibrium modeling of 5-HT(2A) receptors with [18F]deuteroaltanserin and PET: feasibility of a constant infusion paradigm.
van Dyck CH; Soares JC; Tan PZ; Staley JK; Baldwin RM; Amici LA; Fu X; Garg PK; Seibyl JP; Charney DS; Innis RB
Nucl Med Biol; 2000 Nov; 27(8):715-22. PubMed ID: 11150702
[TBL] [Abstract][Full Text] [Related]
16. In vivo binding of [18F]altanserin to rat brain 5HT2 receptors: a film and electronic autoradiographic study.
Biver F; Lotstra F; Monclus M; Dethy S; Damhaut P; Wikler D; Luxen A; Goldman S
Nucl Med Biol; 1997 May; 24(4):357-60. PubMed ID: 9257335
[TBL] [Abstract][Full Text] [Related]
17. [In vivo study of central serotoninergic receptors in man using positron tomography].
Baron JC; Samson Y; Comar D; Crouzel C; Deniker P; Agid Y
Rev Neurol (Paris); 1985; 141(8-9):537-45. PubMed ID: 2935920
[TBL] [Abstract][Full Text] [Related]
18. Analyses of [(18)F] altanserin bolus injection PET data. I: consideration of radiolabeled metabolites in baboons.
Price JC; Lopresti BJ; Mason NS; Holt DP; Huang Y; Mathis CA
Synapse; 2001 Jul; 41(1):1-10. PubMed ID: 11354008
[TBL] [Abstract][Full Text] [Related]
19. In vivo kinetics of [18F](N-methyl)benperidol: a novel PET tracer for assessment of dopaminergic D2-like receptor binding.
Moerlein SM; Perlmutter JS; Markham J; Welch MJ
J Cereb Blood Flow Metab; 1997 Aug; 17(8):833-45. PubMed ID: 9290581
[TBL] [Abstract][Full Text] [Related]
20. Reproducibility of in vivo brain measures of 5-HT2A receptors with PET and.
Soares JC; van Dyck CH; Tan P; Zoghbi SS; Garg P; Soufer R; Baldwin RM; Fujita M; Staley JK; Fu X; Amici L; Seibyl J; Innis RB
Psychiatry Res; 2001 Apr; 106(2):81-93. PubMed ID: 11306248
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]